The HealthMatters Journal — evidence-based health writing
Biomarkers

What is Dihomogamma Linolenic Acid

dihomogamma linolenic acid healthmatters.io

Dihomogamma Linolenic Acid (DGLA) is the elongation product of Gamma-linolenic acid (GLA). GLA, in turn, is a desaturation product (Delta 6 desaturase) of linoleic acid. DGLA is made in the body by the elongation of GLA, by an efficient enzyme which does not appear to suffer any form of (dietary) inhibition. DGLA is an extremely uncommon fatty acid, found only in trace amounts in animal products.

Elevated levels:

DGLA production from GLA is enhanced when high levels of alpha-linolenic acid are present, blocking the arachidonic acid pathway.

Low levels:

Try it on your numbers

Decode your own result in 30 seconds

Enter your value and get a personal interpretation — what your number means in plain language, what to pair it with, and when to follow up.

Decode my result →

Low levels of dihomogamma-linolenic acid result from diets low in both essential fatty acids, LA, and dihomogamma-linolenic acid (DGLA). DGLA is also anti-inflammatory, so an insufficiency of this fatty acid impairs a wide range of cellular functions and tissue responses. When testing reveals low levels of DGLA, supplementation with black currant or evening primrose oils should be considered, but if a history of tumor formation is known, always consider ALA sources (black currant) as well.

Disclaimer:

The information on healthmatters.io is NOT intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice.

HealthMatters.io's avatar
HealthMatters.io

Keep reading

what is sarcosine genova test results meaning interpretation b2 amino acids glycine metabolite high low
Biomarkers · 2 min read

What is Sarcosine?

Sarcosine is also known as N-methylglycine. It is an intermediate and byproduct in the glycine synthesis and degradation. Sarcosine is metabolized to glycine by…

Discover more from HealthMatters: The Journal

Subscribe now to keep reading and get access to the full archive.

Continue reading